Credit Suisse’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Credit Suisse’s Portfolio IBBQ Stock Details IBBQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-400,000	Closed	-$10.4M	–	4461
2021 Q2	$10.4M	Buy	+400,000	New	+$10.2M	0.01%	1543

Other funds holding IBBQ

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

CGL

Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Credit Suisse's IBBQ Position: Q3 2021 in Review

Credit Suisse sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q3 2021, closing a stake of 400,000 shares — an estimated $10.4M sold.

Credit Suisse first reported a position in IBBQ in Q2 2021 and held it in 1 quarter. The position peaked at $10.4M in Q2 2021. 9 funds tracked by Wall St. Rank hold IBBQ as of Q3 2021.

Credit Suisse reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q3 2021 after selling out during the quarter.
Credit Suisse sold 400,000 Invesco NASDAQ Biotechnology ETF shares in Q3 2021, an estimated $10.4M.
Credit Suisse first reported a position in Invesco NASDAQ Biotechnology ETF in Q2 2021 and held it in 1 quarter.
Credit Suisse's Invesco NASDAQ Biotechnology ETF position peaked at $10.4M in Q2 2021.
9 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q3 2021.

Based on Credit Suisse's 13F filing for Q3 2021, filed 12 Nov 2021.